Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00512070
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-02-27
First Post:
2007-08-03
Brief Title:
Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine
Sponsor:
Seattle Institute for Biomedical and Clinical Research
Organization:
Seattle Institute for Biomedical and Clinical Research
Organization Data
Organization:
Seattle Institute for Biomedical and Clinical Research
Class:
OTHER
Study ID:
F1D-MC-X302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Seattle Institute for Biomedical and Clinical Research
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Eli Lilly and Company | INDUSTRY |